CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia Treated with Idarubicin and Cytosine Arabinoside

Publisher： Karger

E-ISSN： 1421-9662|108|1|47-52

ISSN： 0001-5792

Source： Acta Haematologica, Vol.108, Iss.1, 2002-07, pp. : 47-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CD6 Scavenger Receptor Is Differentially Expressed on a CD56dim Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion

By  

Journal of Innate Immunity, Vol. 3, Iss. 4, 2010-12 ,pp. : 420-434

Karger

Access to resources Recommend Favorite

Primary Intracranial Manifestation of CD7/CD56-Positive Acute Myelogenous Leukemia

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 580-582

Karger

Access to resources Recommend Favorite

CD56-Positive Acute Lymphoblastic Leukemia

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 160-163

Karger

Access to resources Recommend Favorite

Primary CD56 + nasal‐type T/natural killer‐cell subcutaneous panniculitic lymphoma: presentation as haemophagocytic syndrome

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 141, Iss. 4, 1999-10 ,pp. : 706-709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extranodal natural killer/T‐cell lymphoma, nasal type, presenting with altered CD56 expression: A case report

By  

THE JOURNAL OF DERMATOLOGY, Vol. 385-2407, Iss. 10, 2015-10 ,pp. : 1022-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite